Atypical Congenital Meduloblastoma: Case Report
Sabina Oblitas Lopez1*, Edgar Pinto Garcia2 and Mauro Toledo Aguirre3
1Neurosurgeon doctor at the National Institute of children's health of San borja – Lima, Peru.
2Neurosurgery resident physician at Hospital III Goyoneche – Arequipa, Peru
3Neurosurgeon doctor at the National Institute of children's health of San borja – Lima, Peru.
*Corresponding Author: Sabina Oblitas Lopez, Neurosurgeon doctor at the National Institute of children's health of San borja – Lima, Peru.
DOI: https://doi.org/10.58624/SVOANE.2024.05.0138
Received: April 06, 2024 Published: May 10, 2024
Abstract
Medulloblastomas are WHO grade 4 embryonal neuroepithelial tumors that typically occur in the posterior fossa in the pediatric population. They represent 68% of embryonal tumors. The study of congenital cases is scarce due to the rarity of reported patients. There is also no specific bibliography, however histologically and molecularly they can be classified. On the other hand, due to the young age of these patients, they are difficult to manage and have a higher risk of complications in the treatment. In addition to this, patients are born with alterations in the development of the central nervous system due to chronic intracranial hypertension caused by said tumor and have little functional development. The objective of this study is to teach us to recognize the diagnosis early, the evolution of the disease to lead to better treatment for these patients in the future.
Keywords: Medulloblastoma, Congenital brain tumors (CBT), Treatment
Citation: Lopez SO, Garcia EP, Aguirre MT. Atypical Congenital Meduloblastoma: Case Report. SVOA Neurology 2024, 5:3, 126-131.
